534 related articles for article (PubMed ID: 24095865)
1. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.
Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865
[TBL] [Abstract][Full Text] [Related]
2. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.
Fadda HM; Merchant HA; Arafat BT; Basit AW
Int J Pharm; 2009 Dec; 382(1-2):56-60. PubMed ID: 19666093
[TBL] [Abstract][Full Text] [Related]
3. An automated system for monitoring and regulating the pH of bicarbonate buffers.
Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
AAPS PharmSciTech; 2013 Jun; 14(2):517-22. PubMed ID: 23468339
[TBL] [Abstract][Full Text] [Related]
4. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
Merchant HA; Goyanes A; Parashar N; Basit AW
Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730
[TBL] [Abstract][Full Text] [Related]
5. Is bicarbonate buffer suitable as a dissolution medium?
Boni JE; Brickl RS; Dressman J
J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
[TBL] [Abstract][Full Text] [Related]
6. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
[TBL] [Abstract][Full Text] [Related]
7. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
8. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
McNamara DP; Whitney KM; Goss SL
Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
Liu F; Shokrollahi H
Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
[TBL] [Abstract][Full Text] [Related]
10. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R
Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131
[TBL] [Abstract][Full Text] [Related]
11. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
[TBL] [Abstract][Full Text] [Related]
12. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.
Sakamoto A; Sugano K
Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285
[TBL] [Abstract][Full Text] [Related]
13. Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO
Al-Gousous J; Sun KX; McNamara DP; Hens B; Salehi N; Langguth P; Bermejo M; Amidon GE; Amidon GL
Mol Pharm; 2018 Nov; 15(11):5291-5301. PubMed ID: 30362350
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of acidic drugs in compendial and physiological hydrogen carbonate buffer from polymer blend-coated oral solid dosage forms.
Wulff R; Rappen GM; Koziolek M; Garbacz G; Leopold CS
Eur J Pharm Sci; 2015 Sep; 77():246-53. PubMed ID: 26093053
[TBL] [Abstract][Full Text] [Related]
15. Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets.
Karkossa F; Klein S
J Pharm Pharmacol; 2017 Oct; 69(10):1327-1340. PubMed ID: 28703304
[TBL] [Abstract][Full Text] [Related]
16. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C
Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
[TBL] [Abstract][Full Text] [Related]
17. Solubility vs Dissolution in Physiological Bicarbonate Buffer.
Claussen F; Al-Gousous J; Salehi N; Garcia MA; Amidon GL; Langguth P
Pharm Res; 2024 May; 41(5):937-945. PubMed ID: 38698196
[TBL] [Abstract][Full Text] [Related]
18. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
Shibata H; Yoshida H; Izutsu K; Goda Y
J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
[TBL] [Abstract][Full Text] [Related]
19. In vivo predictive dissolution: transport analysis of the CO2 , bicarbonate in vivo buffer system.
Krieg BJ; Taghavi SM; Amidon GL; Amidon GE
J Pharm Sci; 2014 Nov; 103(11):3473-3490. PubMed ID: 25212721
[TBL] [Abstract][Full Text] [Related]
20. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M
AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]